TranscriptsNov 03, 2026, 12:48 AM ETVertex Pharmaceuticals Incorporated (VRTX) StockSA Transcripts162.79K FollowersVertex Pharmaceuticals Incorporated (VRTX) Q3 2026 Earnings Call November 2, 2026 4:30 PM ESTCompany ParticipantsSusie Lisa - Senior Vice President of Investor RelationsReshma Kewalramani - CEO, President & DirectorDuncan J. McKechnie - Executive VP & Chief Commercial OfficerCharles Wagner - Executive VP, COO & CFOConference Call ParticipantsCory Kasimov - Evercore ISI Institutional Equities, Research DivisionJessica Fye - JPMorgan Chase & Co, Research DivisionSalveen Richter - Goldman Sachs Group, Inc., Research DivisionGeoffrey Meacham - Citigroup Inc., Research DivisionEvan Seigerman - BMO Capital Markets Equity ResearchBrian Abrahams - RBC Capital Markets, Research DivisionMichael Yee - UBS Investment Bank, Research DivisionTazeen Ahmad - BofA Securities, Research DivisionAkash Tewari - Jefferies LLC, Research DivisionTerence Flynn - Morgan Stanley, Research DivisionMohit Bansal - Wells Fargo Securities, LLC, Research DivisionPresentationOperatorGood day, and welcome to the Vertex Pharmaceuticals Third Quarter 2026 Earnings Call.[Operator Instructions]Please note this event is being recorded. I would now like to turn the conference over to Ms. Susie Lisa. Please go ahead.Susie LisaSenior Vice President of Investor RelationsGood evening, all. My name is Susie Lisa, and as the Senior Vice President of Investor Relations, it is my pleasure to welcome you to our third quarter 2026 financial results conference call. On tonight's call, making prepared remarks, we have Dr. Reshma Kewalramani, Vertex's CEO and President; Charlie Wagner, Chief Operating Officer and Chief Financial Officer; and Duncan McKechnie, Chief Commercial Officer. Given the January 1 transition by Charlie to the COO role solely, please note that this is his last quarterly earnings call and as successor, Jonathan Poole, our current SVP of Finance, will join us for our Q4 2026 call in February.We recommend that you access the webcast slides as you listen to this call. The call is beingRead more current VRTX analysis and newsView all earnings call transcriptsComments